PER 1.27% 8.0¢ percheron therapeutics limited

Ann: ANP to Present at the PPMD Annual Conference 2022, page-71

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,728 Posts.
    lightbulb Created with Sketch. 1461
    Upthefog
    Gennadi Koutchen was a broker at Pattersons
    with an interest in Anp
    After leaving Patterson’s he worked for Tolhurst ( could be the other way around)?
    He was then asked by Anp to join them as a IR.

    He does not have a science degree( so unable to communicate with an investor who want to know the in’s and out’s of our drugs)
    XEC has 3 Accountants and Gennadi as the investor advisor.
    He has no Nett worth clients
    He was lead manager to our Entitlement offer ( I doubt he had the means to finance to underwrite the rights.
    I have been investing in the Stockmarket for 50 yrs
    and spoke to Gennadi on several occasions.
    3 or 4 weeks before the CR I sent Mark a email showing no confidence in Gennadi ( the rest is history)
    i don’t think he was ever a lead manager as such.
    Maybe part of a tem doing a CR but then all brokers do that.
    He should not be working for Anp.



 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.